China Sets New Rule For Drug Price Differentiation
This article was originally published in PharmAsia News
Executive Summary
China’s National Development and Reform Commission Dec. 2 releases new regulation on drug price differentiation intended to close loopholes.
You may also be interested in...
China's Next Round Of Drug Price Cuts? NDRC To Slash Prices On More Products On National Drug Reimbursement List
SHANGHAI - China's New Drug Price Guidelines are expected to be released by the end of this year, which are likely to lead to another round of price cuts on drugs included on the National Drug Reimbursement List, according to analysts
China Boosts Health System Reforms With Expanded National Drug Reimbursement List
BEIJING - In the government's latest move to expand coverage under sweeping health system reforms that are in the works China-wide, the Ministry of Human Resources and Social Security has added hundreds of new medicines to the latest edition of the national drug reimbursement catalog
China Braces As Trump Orders 'Buy American' For Essential Medicines
As the largest manufacturer of active pharmaceutical ingredients globally, China is bracing for more uncertainty amid the global pandemic and fast-changing environment, particularly in the US.
Need a specific report? 1000+ reports available
Buy Reports